Suchergebnisse - "Gooderham, Melinda"

PubPharm (326)

1

Sustained Improvements in Clinical and Patient-Reported Outcomes and Quality of Life Through 5 Years Among Ixekizumab-Treated Patients with Complete Clearance of Scalp Psoriasis by Week 60

enthalten in: Dermatology and therapy | 2024

von Egeberg, A. | Hawkes, J. | Somani, N. | +7

2

Roflumilast foam 0.3% for adolescent and adult patients with seborrheic dermatitis : A randomized, double-blinded, vehicle-controlled, phase 3 trial

enthalten in: Journal of the American Academy of Dermatology | 2024

von Blauvelt, A. | Draelos, Z. | Stein Gold, L. | +18

3

Dysregulation of epigenetic, biological and mitotic age in the context of biologic drug treatment and phototherapy in plaque psoriasis patients

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2024

von Jeremian, R. | Lytvyn, Y. | Fotovati, R. | +8

4

Efficacy of long-term risankizumab treatment for moderate-to-severe plaque psoriasis : Subgroup analyses by baseline characteristics and psoriatic disease manifestations through 256 weeks (LIMMitless trial)

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2024

von Strober, B. | Bachelez, H. | Crowley, J. | +9

5

Sustained Improvements in Clinical and Patient-Reported Outcomes and Quality of Life Through 5 Years Among Ixekizumab-Treated Patients with Complete Clearance of Scalp Psoriasis by Week 60

enthalten in: Dermatology and therapy | 2024

von Egeberg, A. | Hawkes, J. | Somani, N. | +7

6

Long-term safety and effectiveness of roflumilast cream 0.3% in adults with chronic plaque psoriasis : a 52-week, phase 2, open-label trial

enthalten in: Journal of the American Academy of Dermatology | 2024

von Stein Gold, L. | Adam, D. | Albrecht, L. | +18

7

Characterization of disease burden, treatment and comorbidities in a large, real-world cohort of patients with atopic dermatitis : The CorEvitas Atopic Dermatitis Registry

enthalten in: JAAD international | 2024

von Silverberg, J. | Cronin, A. | Jones, E. | +8

8

Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis : 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2)

enthalten in: American journal of clinical dermatology | 2024

von Silverberg, J. | Gooderham, M. | Paller, A. | +13

9

Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program

enthalten in: American journal of clinical dermatology | 2024

von King, B. | Soung, J. | Tziotzios, C. | +12

10

Current Practices of Allergy Testing in Adults With Atopic Dermatitis in Canada : A National Survey

enthalten in: Journal of cutaneous medicine and surgery | 2024

von Lee, E. | Turchin, I. | Chan, A. | +12

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[33]